Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The objective of this phase I study is to determine the maximum tolerated dose (MTD) of
combination therapy of paclitaxel and everolimus in small cell lung cancer patient with
previous treatment history.